College of Medicine, The Catholic University of Korea, St. Mary's Hospital
Seoul, 150-713, South Korea
NCT Number: NCT00570362
The purpose of this study is to evaluate whether systemic glutathione level is decreased in patients with normal tension glaucoma.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Observational
Seoul, 150-713, South Korea
Normal tension glaucoma is one of the most common cause of primary open angle glaucoma in Korea. Even though, we still do not know what the cause is. Only IOP-lowering drugs are the currently available therapeutic method. Glutathione is one of the mostly high concentrated intracellular antioxidants. We find apoptosis of neuronal cell in the mouse retina by systemic depletion of glutathione using buthionine sulfoximine. Glutathione is also known to be reduced in primary open angle glaucoma with high IOP. So we are planning to evaluate systemic glutathione level in normal tension glaucoma.
Blood samples will be obtained by venipuncture to the antecubital vein of normal tension glaucoma patients and age-matched normal controls. Five milliliters of blood will be collected in EDTA-treated tubes (to prevent oxidation). Thirty microliters of blood will be then transferred into centrifuge tubes, and will be added 33.3 microliter of 5-sulfosalicylic acid (SSA), 100mg/mL within 10 minutes from the blood collection.Each sample will be then diluted with 936.7 microliter sodium phosphate buffer (pH 7.5), and the content of each tube will be mixed rapidly in a centrifuge at 13,000 rpm for 5 minutes. A portion of supernatant (150 microliter) will be then collected into clean centrifuge tubes and immediately cooled at -70°C. To each well of a 96-well plate, 150 microliter of daily buffer (3 mg NADPH into 10 mL sodium phosphate buffer), 50microliter of DTNB solution, and 25 microliter of standards or samples will be added in quadruplicate, and the plate will be incubated at 37 °C for 3 minutes.Finally, 25 microliter GSSGR will be added to the previous mixture, and the plate will be read at 410 nm using a 96-well plate reader(UV spectrophotometer).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Patients were included in the normal tension glaucoma group according to the following criteria.
Inclusion criteria
(normal tension glaucoma group):
Exclusion criteria
(normal tension glaucoma group):
The control group was composed of age-matched healthy volunteers who had neither glaucoma nor other ocular diseases such as cataract, diabetic retinopathy or age related macular degeneration. The control group did not show any glaucomatous optic disc cupping on fundoscopic examination or visual field defects with program 24-2 of the Humphrey Field Analyzer. The healthy volunteers in the control group must be able to provide intravenous blood sampling.
Exclusion criteria
for both groups:
Time frame: Once in the morning.
Subjects were instructed to fast from midnight to 8 AM on the morning of the test. All blood samples were obtained by a qualified registered nurse in the morning, between 8 and 10 AM.
The Catholic University of Korea
Other
Evaluation of Systemic Glutathione Level in Patients With Normal Tension Glaucoma
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06449352
Eye Diseases, Glaucoma
Austin, Texas, United States
View Trial DetailsNCT06266351
Eye Diseases, Glaucoma
Tucson, Arizona, United States
View Trial DetailsNCT01254149
Eye Diseases, Glaucoma
Omaha, Nebraska, United States
View Trial DetailsNCT04014933
Eye Diseases, Glaucoma
Zurich, Canton of Zurich, Switzerland
View Trial Details